Tag Archives: postmarketing surveillance

Metal-on-Metal Hips: A Tale of Harm, Weak
Medical Device-Approval, and Lax Postmarket Scrutiny

Posted on February 28, 2012 by Laura Newman

Nearly 1 million metal-on- metal hips have been implanted in patients in the United States, making the US the world’s largest consumer of the implants. According to a BMJ/BBC Newsnight Investigation released today, the “risks associated with these devices have … Continue reading →

Posted in medical devices | Tagged , , , , , , , , | 6 Comments

Inattention to Drug Safety in the Elderly
Leaves Generations At Risk

Posted on July 5, 2011 by Laura Newman

This post originally appeared in a slightly different form in Scientific American’s guest blog on June 30, 2011. My frail, 92-year-old mother was prescribed 80 mg of the cholesterol-lowering drug, or statin, simvastatin (Zocor) for years, possibly decades. She fell … Continue reading →

Posted in aging, drug safety, falls | Tagged , , , , , , | 2 Comments